Skip to Content
 

VICC toll-free number 1-877-936-8422

Head and Neck Cancers

Although head and neck cancer is a common malignancy, there are few programs in the country that have dedicated, multidisciplinary teams to treat a large number of patients. The Vanderbilt-Ingram Cancer Center has a nationally recognized Head and Neck Cancer Program which is staffed by expert surgeons, a full-time medical oncologist and full-time radiation oncologists.

Clinical Trials for Head and Neck Cancers

14 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

VICCHN0603

04/28/2006

Effect of PI3K Inhibition in HPV Infected Cell (deidentified)

Basic Science

VICCHN0529

05/10/2005

Novel Protein Regulator of Tumor Suppressor ARF & NF-kB (NIH/2 R01 DEO13173-05) (deidentified)

Basic Science

VICCHN0530

04/08/2005

Serum Biomarkers for Head & Neck Cancer (deidentified)

Basic Science

VICCHN0356

02/04/2003

Head and Neck Tumor Tissue Repository and Clinical Database

Other

VICCHN15135

09/28/2016

Assessing Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors

Other

VICCSUPP14137

09/23/2016

Characterization of Chronic Systemic Symptoms among Participants in the Fibrosis Lymphedema Continuum Study in Head and Neck Cancer

Other

VICCSUPP1517

10/16/2015

A Qualitative Study to Explore Patients' Experience of Squamous Cell Carcinoma of the Head and Neck (SCCHN) and Evaluate Relevant Patient-Reported Outcome Measures for Clinical Trials

Other

VICCSUPP1530

04/14/2015

A Patient-Centered Outcomes Study of Patients with Recurrent Head and Neck Cancer

Supportive Care

VICCSUPP1529

06/08/2015

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Treatment

VICCMD15110

04/05/2016

A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

Treatment

VICCHN1574

03/21/2016

A Randomized, Multicenter, Double-Blind Phase 2 Study of Palbociclib plus Cetuximab versus Cetuximab for the Treatment of Human Papillomavirus -Negative, Cetuximab-Naive Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck After Failure of One Prior Platinum-Containing Chemotherapy Regimen

Treatment

VICCPHI1531

03/01/2016

A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers

Treatment

VICCPHI1588

11/27/2015

A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors

Treatment

ECOGHNE1305-M

02/11/2009

A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer